4 completed, 1 terminated, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
Follow Active Rheumatoid Arthritis: new trials by email Literature Review of Active Rheumatoid Arthritis trials Research Report on Active Rheumatoid Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulse Steroid Injection in Refractory Rheumatoid Arthritis Solumedrol - Active Rheumatoid Arthritis | Phase 3 | Unknown | Sohag University | 268 | 2024-05-01 | 2024-06-13 |
| Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA Adalimumab, Methotrexate, Folic Acid - Active Rheumatoid Arthritis | Phase 3 | Completed | Cinnagen | 136 | 2015-11-18 | 2021-02-02 |
| To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis Treatment I, Treatment II, Treatment III - Active Rheumatoid Arthritis | Phase 3 | Terminated | Sun Pharmaceutical Industries Limited | 150 | 2015-11-01 | 2021-11-19 |
| Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 CDP870 - Active Rheumatoid Arthritis | Phase 3 | Completed | Astellas Pharma Inc | 86 | 2011-01-01 | 2015-11-16 |
| A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Abatacept, Placebo - Active Rheumatoid Arthritis | Phase 3 | Completed | Bristol-Myers Squibb | 50 | 2007-05-01 | 2012-01-18 |
| Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. Etanercept - Active Rheumatoid Arthritis | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 615 | 2000-10-01 | 2023-12-13 |
Arthritis (1) · Arthritis, Rheumatoid (1)
Joint Diseases (2) · Musculoskeletal Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Rheumatic Diseases (1) · Skin and Connective Tissue Diseases (1)
Abatacept (1) · Adalimumab (1) · Certolizumab Pegol (1) · Etanercept (1) · Folic Acid (1) · Methotrexate (1) · Methylprednisolone Hemisuccinate (1) · Prednisolone (1)
Astellas Pharma Inc (1) · Bristol-Myers Squibb (1) · Cinnagen (1) · Sohag University (1) · Sun Pharmaceutical Industries Limited (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Belgium (3) · Netherlands (3) · Germany (2) · Spain (2) · Sweden (2) · United Kingdom (2) · Australia (1) · Austria (1) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · Greece (1) · Iran (1)
Ahmadreza Jamshidi, Professor (1)